log in
Print | Back

Haynes and Boone, LLP

Neil Issar

Neil Issar



  • False Claims Act/Qui Tam
  • FDA - Medical Device, Food and Cosmetics
  • Foreign Corrupt Practices Act (FCPA)
  • Fraud, Abuse, and Compliance

WSG Practice Industries


Neil Issar is an associate in the Litigation Practice Group in the Dallas office of Haynes and Boone.

His practice focuses on government investigations, white collar defense, fraud and abuse laws, navigation of regulatory and compliance issues involving the healthcare industry, and the defense of healthcare and other clients in litigation.

At Vanderbilt Law School, Neil worked as a research assistant for multiple professors, conducting independent studies on the detection and prosecution of healthcare fraud and the admissibility of statistical proof in medical reimbursement coding cases. Before law school, Neil gained experience in medical research, designing and directing various patient-centered clinical trials and health policy studies.

Bar Admissions

Texas, 2016


J.D., Vanderbilt University Law School, 2016, Articles Editor, Vanderbilt Journal of Entertainment & Technology Law
B.S., McGill University, 2010
Areas of Practice

False Claims Act/Qui Tam | FDA - Medical Device, Food and Cosmetics | Foreign Corrupt Practices Act (FCPA) | Fraud, Abuse, and Compliance | Government Enforcement and Litigation | Health Privacy (HIPAA) and Healthcare IT | Healthcare and Life Sciences | Internal Investigations and Crisis Management | Litigation | Privacy and Data Security


COVID-19 Quick Reference Regulatory Guide for Healthcare Providers
Haynes and Boone, LLP, May 2020

As healthcare providers respond to increased demands on supplies and resources due to the COVID-19 pandemic, regulators have issued certain flexibilities and guidance in responding to the public health emergency. The following guide and frequently asked questions are designed to address some of the more common issues and questions that providers face. As always, legal advice is fact-sensitive...

Could Retention of PPP Loan Funds Create False Claims Act Liability?
Haynes and Boone, LLP, May 2020

The Paycheck Protection Program (“PPP”) is intended to provide nearly $700 billion of economic relief to small businesses adversely affected by COVID-19...

New Law Provides $100 Billion of Additional Healthcare Funding for COVID-19 Response
Haynes and Boone, LLP, April 2020

Today, the federal government enacted the Paycheck Protection Program and Health Care Enhancement Act (the “PPP/HCE Act”) to provide additional funding for loan and grant programs in response to the COVID-19 pandemic. The PPP/HCE Act modifies and increases funding for the Paycheck Protection Program and the Small Business Administration Economic Injury Disaster Loan program, as discussed in greater detail here...

WSG's members are independent firms and are not affiliated in the joint practice of professional services. Each member exercises its own individual judgments on all client matters.

HOME | SITE MAP | GLANCE | PRIVACY POLICY | DISCLAIMER |  © World Services Group, 2021